Antiplatelet drug therapy: role of pharmacodynamic and genetic testing

Author： Tello-Montoliu Antonio   Ueno Masafumi   Angiolillo Dominick J  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.7, Iss.3, 2011-05, pp. : 381-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Drug Interactions Associated with Antiplatelet Therapy

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 4, 2011-10 ,pp. : 231-240

Bentham Science Publishers

Access to resources Recommend Favorite

Interest of Antiplatelet Drug Testing after an Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 135-139

Karger

Access to resources Recommend Favorite

Platelet Function and Antiplatelet Therapy in Cardiovascular Disease: Implications of Genetic Polymorphisms

By  

Current Vascular Pharmacology, Vol. 9, Iss. 4, 2011-07 ,pp. : 479-489

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Perspectives on the Role of Anti-Platelet and Statin Therapy in Patients with Vascular Diseases

By  

Current Vascular Pharmacology, Vol. 1, Iss. 3, 2003-10 ,pp. : 329-333

Bentham Science Publishers

Access to resources Recommend Favorite

Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 55-60

Bentham Science Publishers

Access to resources Recommend Favorite